Is There a Role for Multiple Lines of Anti-HER2 Therapies Administered Beyond Progression in HER2-Mutated Non-Small Cell Lung Cancer? A Case Report and Literature Review

Oncogene-addicted non-small cell lung cancer (NSCLC) comprises a number of distinct disease subtypes, each of which is characterised by druggable genetic alterations. Among them, the receptor tyrosine kinase protein human epidermal receptor 2 (HER2) is occasionally found deregulated via gene mutatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Metro, Giulio, Baglivo, Sara, Moretti, Riccardo, Bellezza, Guido, Sidoni, Angelo, Roila, Fausto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683654/
https://www.ncbi.nlm.nih.gov/pubmed/32700047
http://dx.doi.org/10.1007/s40487-020-00121-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683654/
https://www.ncbi.nlm.nih.gov/pubmed/32700047
http://dx.doi.org/10.1007/s40487-020-00121-5

Ejemplares similares